Research - New York, New York, United States
At Bioharmony Therapeutics, we are developing nontraditional antimicrobial therapeutics by exploiting millions of years of phage-bacteria evolution. Our focus is on targeting infectious diseases caused by multidrug-resistant (MDR) Gram-negative bacteria. Our primary therapeutic indication is for Acinetobacter baumannii skin and wound infections.
DoubleClick
Gmail
Route 53
Facebook Login (Connect)
Google Apps
CloudFlare Hosting